TCT 2018
Details
Date
- America/New_York
Daniel J.F.M Thuijs
Daniel J.F.M Thuijs is a cardiology at Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands.
Read MoreDaniel J.F.M Thuijs is a cardiology at Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands.
Show LessDr. William Fearon
Dr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia...
Read MoreDr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Cardiology and Director of Interventional Cardiology at Stanford University School of Mediciner. Dr. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology, the American Heart Association, and the Society of Cardiovascular Angiography and Interventions. He has been elected to the American Society for Clinical Investigation. Dr. Fearon’s primary area of research interest is in coronary physiology. He was the US principal investigator and senior author of the FAME trial, published in the New England Journal of Medicine and was a co-principal investigator and senior author of the FAME 2 trial, also published in the New England Journal of Medicine. He is now the principal investigator of the international FAME 3 trial comparing bypass surgery to fractional flow reserve guided percutaneous coronary intervention. He serves on the editorial board of the Journal of the American College of Cardiology, Circulation, JACC Cardiovascular Interventions, and Circulation: Cardiovascular Interventions. He was the principal investigator on an R01 and is the PI on an R61/R33 NIH award evaluating cardiac allograft vasculopathy early after transplantation. Dr. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement. He was a coauthor on the PARTNER 2A Trial published in the New England Journal of Medicine.
Show LessGert Richardt
Gert Richardt is a consultant cardiologist at Heart Center, Segeberger Kliniken GmbH (Academic...
Read MoreGert Richardt is a consultant cardiologist at Heart Center, Segeberger Kliniken GmbH (Academic Teaching Hospital of the Universities of Kiel, Lübeck and Hamburg), Bad Segeberg, Germany.
Show LessHorst Sievert
A consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 63 videos on...
Read MoreA consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 63 videos on Wondr Medical. Horst Sievert generally speaks on Atrial Fibrillation, Left Atrial Appendage (Closure), Live Cases, Transcatheter Aortic Valve Implantation (TAVR / TAVI), and Left Main Stem (LMS).
Show LessHoward Herrmann
Works at Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Features in 20 videos...
Read MoreWorks at Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Features in 20 videos on Wondr Medical. Howard Herrmann generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI), Mitral, Mitral regurgitation, MitraClip, and Structural Cardiac Interventions.
Show LessJoost Daemen
Joost Daemen is an interventional cardiology at Thorax Centre Erasmus MS, Rotterdam, The...
Read MoreJoost Daemen is an interventional cardiology at Thorax Centre Erasmus MS, Rotterdam, The Netherlands.
Show LessJorg Hausleiter
Jorg Hausleiter is an interventional cardiology at Medizinische Klinik und Poliklinik, Munich, DE.
Read MoreJorg Hausleiter is an interventional cardiology at Medizinische Klinik und Poliklinik, Munich, DE.
Show LessJunjie Zhang
Works at Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Features in 1 video...
Read MoreWorks at Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Features in 1 video on Wondr Medical. Junjie Zhang generally speaks on Imaging.
Show LessJustin Davies
Dr Justin Davies is a honorary interventional cardiologist at Hammersmith Hospital, Imperial...
Read MoreDr Justin Davies is a honorary interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents, he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).
Show LessLars Sondergaard
Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark....
Read MoreProfessor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).
Show LessMichael Joner
Works at Deutsches Herzzentrum Muenchen, Munich, Bayern, Germany. Features in 13 videos on Wondr...
Read MoreWorks at Deutsches Herzzentrum Muenchen, Munich, Bayern, Germany. Features in 13 videos on Wondr Medical. Michael Joner generally speaks on Stents, Drug Eluting Stents (DES), Peripheral Vascular Disease (PVD), Intravascular Ultrasound (IVUS), and Coronary Optical Coherence Tomography (OCT).
Show LessNicolas Van Mieghem
Nicolas Van Mieghem is the Clinical Director of Interventional Cardiology and Professor of...
Read MoreNicolas Van Mieghem is the Clinical Director of Interventional Cardiology and Professor of Interventional Cardiology at the Thoraxcenter, Erasmus University Medical Center, Rotterdam. He obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent Fellowships in interventional cardiology in at Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, United States and Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands, he joined the senior staff of the department of interventional cardiology in the Thoraxcenter in February 2010. Professor Van Mieghem’s academic interest is in complex (calcified) coronary lesions, mechanical circulatory support and structural heart interventions. He obtained a PhD based upon his research in transcatheter valve therapies. Professor Van Mieghem is involved in the percutaneous coronary interventions and structural heart program. Professor Van Mieghem has published and co-authored over 400 scientific papers in peer-reviewed journals. He is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and the American College of Cardiology.
Show LessPatrick Serruys
Prof Patrick W. Serruys with respected h-index – 183 is a professor of Interventional...
Read MoreProf Patrick W. Serruys with respected h-index – 183 is a professor of Interventional Cardiology at the Interuniversity Cardiological Institute of the Netherlands (1988-1998) and Erasmus MC. Since 1980 he was a Director of the Clinical Research Program of the Catheterization Laboratory, Thorax Center at Erasmus University, and till April 1, 2014 (retirement date) the Head of the Interventional Department, Thorax Center, Erasmus MC (University Medical Center Rotterdam), Rotterdam, The Netherlands. Since April 2013, he holds the position of Professor of Cardiology in the Cardiovascular Science Division of the National Heart and Lung Institute (NHLI) at the Faculty of Medicine, within the Imperial College of Science, Technology and Medicine, London.He is a Fellow of the American College of Cardiology and a Fellow of the European Society of Cardiology and scientific council of the International College of Angiology.In 1996, he received the TCT Career Achievement Award and in 1997 he was awarded the Wenkebach Prize of the Dutch Heart Foundation. In 2000, he was awarded the Gruentzig Award of the European Society of Cardiology. In 2001, he held the Paul Dudley White Lecture at the American Heart Association in the USA. In 2004, he received the Andreas Gruentzig Award of the Swiss Society of Cardiology. In 2005, he held the 4th International Lecture at the AHA and Mikamo Lecture at the Japanese heart Association. In 2006, he received the highest award of the Clinical Council of the American Heart Association: the James Herrick Award. In 2007, he received the Arrigo Recordati International Prize (Italy) and the ICI Achievement Award (bestowed by the President of Israel – Shimon Perez). In 2008, he received the Einthoven Penning (Leiden). In 2009, he became Doctor Honoris Causa from the University of Athens. In 2011, he received the Lifetime Achievement Award, bestowed by the American College of Cardiology, in recognition of many years of service and invaluable contributions to the ACC. At the end of 2011, Prof Serruys received the Ray C. Fish Award, bestowed by the Texas Heart Institute, for outstanding achievement and contribution to cardiovascular medicine. In 2012, he received a Golden Medal of the European Society of Cardiology. In 2013, he became Doctor Honoris Causa from the Complutense University of Madrid. In 2016, he became Doctor Honoris Causa of the Melbourne University, Australia. Currently he is established Professor of Interventional Medicine and Innovation at the National University of Ireland, Galway.
Show LessPhilipp Lurz
Philipp Lurz is a consultant cardiologist at University Hospital Leipzig, Leipzig, Germany.
Read MorePhilipp Lurz is a consultant cardiologist at University Hospital Leipzig, Leipzig, Germany.
Show LessPieter Smits
Pieter Smits works at Maasstad Ziekenhuis, Rotterdam, Netherlands.
Read MorePieter Smits works at Maasstad Ziekenhuis, Rotterdam, Netherlands.
Show LessPieter Stella
Pieter Stella is a consultant cardiologist at University Medical Centre Utrecht, The Netherlands.
Read MorePieter Stella is a consultant cardiologist at University Medical Centre Utrecht, The Netherlands.
Show LessRobert Byrne
Prof. Byrne graduated from University College Dublin, Ireland and completed his PhD in Medical...
Read MoreProf. Byrne graduated from University College Dublin, Ireland and completed his PhD in Medical Life Science and Technology at the Technical University Munich, Germany. Research awards received include the ESC Atherothrombosis Research Fellowship (2008), the TCT Thomas J. Linnemeier Young Investigator Award (2009) and the Andreas Grüntzig Research Prize of the German Cardiac Society (2016). Leadership roles include Deputy Editor at EuroIntervention and board member of EAPCI and Chair of its Patient Initiatives Committee.
Show LessSameer Gafoor
A consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 7 videos on...
Read MoreA consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 7 videos on Wondr Medical. Sameer Gafoor generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI), Mitral, Aortic Pathology, Aortic Valve Pathology, and Aortic dissection.
Show LessToby Rogers
Dr. Rogers is an interventional cardiologist and scientific lead for the MedStar Heart & Vascular...
Read MoreDr. Rogers is an interventional cardiologist and scientific lead for the MedStar Heart & Vascular Institute Structural Heart Disease program. He has a special interest in all aspects of minimally invasive treatment of structural heart disease, including Transcatheter Aortic Valve Replacement (TAVR), Transcaval access, Transcatheter Electrosurgery (LAMPOON and BASILICA techniques), para-valvular leak closure, percutaneous treatment of mitral valve regurgitation including Mitraclip and Transcatheter Mitral Valve Replacement (TMVR), LAA occluder, percutaneous pulmonary and tricuspid valve interventions, and cerebral protection devices for TAVR.
Show LessTom Ford
Tom is a patient-centred Interventional Cardiologist at Gosford Hospital on Northern Sydney's...
Read MoreTom is a patient-centred Interventional Cardiologist at Gosford Hospital on Northern Sydney's Central Coast (NSW, Australia). He was born in Edinburgh and attended the University of Dundee graduating aged 22 with MBChB (Hons) receiving the Captain WA Low Prize and Medal as most distinguished graduate in Medicine. He emigrated to Australia 10 years ago after gaining the MRCP at the Royal College of Physicians in Edinburgh. In 2015, he completed his FRACP during advanced cardiology training in Sydney (Prince of Wales Hospital and St George Hospital). In 2019, Dr Ford returned from a three-year fellowship in Glasgow (Golden Jubilee National Hospital). This centre has the largest volume for coronary stents in the UK and his cardiology training in two continents exposed him to a high volume of interventional cardiology procedures including complex cardiac intervention, acute emergency percutaneous coronary intervention (i.e. emergency intervention for heart attack), advanced multimodal coronary imaging, structural heart interventions and novel invasive therapies for resistant hypertension. During his time in Glasgow, he developed his research interest in coronary artery disease performing an internationally recognized clinical trial involving invasive physiological testing for angina patients helping to improve their quality of life. His PhD was submitted in 2019 to the University of Glasgow and won the Bellahouston Medal as the highest distinction for the excellence of theses submitted for the degrees of MD, DDS and PhD. This work is directly relevant to help diagnose and manage patients with angina, chest pain and/or breathlessness. He is an Honorary Clinical Lecturer at the University of Glasgow and a Senior Lecturer at University of Newcastle (NSW). Dr Ford is an invited speaker and faculty at leading international cardiology scientific sessions including EuroPCR, Transcatheter Cardiovascular Therapeutics (TCT in USA) and European Society of Cardiology (ESC congress). His research has been published in leading cardiology journals and was recently recognized with two accolades including EuroPCR Best Abstract (Winner PCR’s Got Talent) and from the British Cardiac Society (‘Best of the Best’ Clinical Abstract – Interventional Cardiology). Outside of work, Tom is a golfer, surfer, runner and enjoys spending time with his wife (Naomi) and dog (Maisie).
Show LessWilliam Gray
Works at Lankenau Heart Institute, Main Line Health, Wynnewood, PA. Features in 8 videos on Wondr...
Read MoreWorks at Lankenau Heart Institute, Main Line Health, Wynnewood, PA. Features in 8 videos on Wondr Medical. William Gray generally speaks on Stroke, Peripheral Vascular Disease (PVD), Stroke: LAA and LAA closure, Left Atrial Appendage (Closure), and Venous (PVD).
Show Less